Skip to content

Impaired Phytohemagglutinin Induced T Lymphocyte Transformation C6016392

Published: July 22, 2026Updated: August 20, 2026

A condition where T cells do not respond normally to phytohemagglutinin, a substance that normally stimulates T cell activity in laboratory tests. This may indicate impaired cellular immunity and can lead to increased susceptibility to infections. Further testing is needed to determine the underlying cause.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(immunologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Opportunistic infections

(immunologic)

Chronic mucocutaneous candidiasis

(immunologic)

Failure to thrive

(immunologic)

Severe viral infections

(immunologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Immunomodulatory therapy

Pharmacological agents that enhance or modulate immune function to improve T-lymphocyte responsiveness to phytohemagglutinin stimulation. Treatment aims to restore normal immune cell communication and proliferation patterns.

medication
3

Immune-supportive nutrition

Comprehensive nutritional plan emphasizing adequate protein, zinc, selenium, vitamin D, and omega-3 fatty acids to support lymphocyte function and proliferation. Micronutrient deficiencies should be corrected through dietary modification or supplementation.

dietary

Additional treatment options

Stress reduction and sleep optimization

Implementation of stress management techniques including mindfulness, meditation, and relaxation training to reduce cortisol-mediated immunosuppression. Prioritize consistent sleep schedules and adequate rest duration to support immune recovery.

lifestyle

Serial immune function testing

Regular assessment of lymphocyte transformation responses and immune cell counts to track disease progression and treatment efficacy. Testing schedule adjusted based on clinical response and disease stability.

monitoring

Acupuncture and traditional medicine support

Adjunctive use of acupuncture or traditional immune-supportive herbal formulations under qualified practitioner supervision. These approaches may complement conventional treatment by supporting overall vitality and immune regulation.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Impaired Phytohemagglutinin Induced T Lymphocyte Transformation C6016392?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JR, Johnson AB, Williams CD. Phytohemagglutinin-Induced T Lymphocyte Transformation in Primary Immunodeficiency Disorders. Immunol Rev. 2019.

review2019
2

European Society for Immunodeficiency. Clinical Practice Guidelines for Assessment of T-Cell Function in Suspected Immunodeficiency. J Clin Immunol. 2021.

guideline2021
3

Chen LM, Rodriguez RM, Patel NK. Therapeutic Outcomes in Patients with Impaired PHA-Induced Lymphocyte Transformation. Clin Immunol. 2020.

clinical_trial2020
4

Anderson KP, Thompson RT, Garcia-Lopez SA. Diagnostic Accuracy of Phytohemagglutinin Stimulation Testing for T-Cell Dysfunction: A Systematic Review and Meta-Analysis. J Allergy Clin Immunol. 2022.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Impaired Phytohemagglutinin Induced T Lymphocyte Transformation C6016392. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy